Keyphrases
Leukemia Patients
100%
Acute Myeloid Leukemia
100%
Newly Diagnosed
100%
Current Pattern
100%
Induction Chemotherapy
100%
Fresh Frozen Plasma
100%
Blood Product Use
100%
Confidence Interval
66%
Hazard Ratio
66%
Red Blood Cells
66%
FLT3-ITD
66%
Patient Care
33%
Multivariate Analysis
33%
Supportive Care
33%
Hemoglobin Level
33%
Retrospective Analysis
33%
Overall Survival
33%
Intermediate Risk
33%
Blood Platelets
33%
Transfusion Requirements
33%
Nucleophosmin 1 (NPM1)
33%
Red Blood Cell Units
33%
Favorable Risk
33%
De Novo Acute Myeloid Leukemia
33%
Cryoprecipitate
33%
Blood Group
33%
Blood Product Transfusion
33%
Blood Group O
33%
Platelet Transfusion
33%
Prognostic Impact
33%
Platelet Levels
33%
Transfusion Dependency
33%
Transfusion Support
33%
Transfusion Burden
33%
Outcome Predictive Factors
33%
Clinical Trajectory
33%
ELN 2017
33%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Erythrocyte
100%
Induction Chemotherapy
100%
Fresh Frozen Plasma
100%
Blood Product
100%
Hazard Ratio
66%
Platelet
66%
Multivariate Analysis
33%
Supportive Care
33%
Overall Survival
33%
Predictive Factor
33%
NPM1
33%
De Novo Acute Myeloid Leukemia
33%
Thrombocyte Transfusion
33%
Blood Group O
33%
Blood Group AB
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Acute Myeloid Leukemia
100%
Fresh Frozen Plasma
100%
Overall Survival
33%
De Novo Acute Myeloid Leukemia
33%